K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: An in vivo study using the severe combined immunodeficient mouse-human skin model

Journal of Investigative Dermatology

Volumn 122, Issue 3, 2004, Pages 812-819

  Raychaudhuri, Siba P ^a   Sanyal, Mrinmoy ^a   Weltman, Helena ^a   Kundu Raychaudhuri, Smriti ^a,b,c  

^a Psoriasis Research Institute   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; K 252A; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROPEPTIDE; NEUTRALIZING ANTIBODY; PLACEBO;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NERVE REGENERATION; NEUROGENIC INFLAMMATION; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; RECEPTOR UPREGULATION; SCID MOUSE; SKIN NERVE; STUDENT T TEST; T LYMPHOCYTE ACTIVATION;

EID: 1842689793     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2003.12602.x     Document Type: Article

References (58)

1. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ: Neuropeptides and general neuronal marker in psoriasis - An immunohistochemical study. Clin Exp Dermatol 20:384-389, 1995
2. Allsopp TE, Robinson M, Wyatt S, Davies AM: Ectopic trkA expression mediates a NGF survival response in NGF-independent sensory neurons but not in parasympathetic neurons. J Cell Biol 123:1555-1566, 1993
3. Aloe L, Levi-Mantalcini R: Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 133:358-366, 1977
4. Barbacid M: Nerve growth factor: A tale of two receptors. Oncogene 8:2033-2042, 1993
5. Berg MM, Sternberg DW, Parada LF, Chao MV: K252a inhibits nerve growth factor induced trk protoco-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 267:13-16, 1992
6. Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH Jr: Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 15:504-507, 1936
7. Bischoff SC, Dahinden CA: Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79:2662-2669, 1992
8. Bothwell M: Keeping track of neurotrophin receptors. Cell 65:915-918, 1991
9. Calleja T, Enriquez PR, Filloux C, Peraldi P, Baron V, Van Obberghen E: The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase receptor. Endocrinobgy 138:1111-1120, 1997
10. Camisa C, O'Dorisio TM, Maceyko RF, Schacht GE, Mekhjian HS, Howe BA: Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-295 (sandostatin). I. An open label pilot study. Cleve Clin J Med 57:71-76, 1990
11. Cordon-Cardo C, Tapley P, Jing SQ, et al: The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66:395-403, 1991
12. Davies A: Neurotrophins: The Yin and Yang of nerve growth factor. Curr Biol 7:38-40, 1997
13. Devor M, Schonfeld D, Seltzer Z, Wall P: Two modes of cutaneous reinnervation following peripheral nerve injury. J Comp Neurol 185:211-220, 1979
14. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R: Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 268:22836-22846, 1993
15. Ehrnard PB, Erb P, Graumann U, Otten U: Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated Cd4-positive T cell clones. Immunology 90:10984-10988, 1993
16. Ehrhard PB, Erb P, Graumann U, Schutz B, Otten U: Expression of functional trk tyrosine kinase receptors after T cell activation. J Immunol 152:2705-2709, 1994
17. Fantini F, Magnoni C, Brauci-Laudeis L, Pincelli C: Nerve growth factor is increased In psoriatic skin. J Invest Dermatol 105:854-855, 1995
18. Farber EM, Cohen EN, Trozak DJ, Wilkinson DI: Peptide T improves psoriasis when infused into lesions in nanogram amounts. J Am Acad Dermatol 25:658-664, 1991
19. Farber EM. Nickoloff BJ, Recht B, Fraki JE: Stress, symmetry, and psoriasis: Possible role of neuropeptides. J Am Acad Dermatol 14:305-311, 1986
20. Gilhar A, David M, Ulmann Y, Berkutski T, Kalish RS: T lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mouse. J Invest Dermatol 109:283-289, 1997
21. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MD: High-affinity NGF binding requires co-expression of the trk proto-oncogene and low-affinity NGF receptor. Nature (London) 350:678-683, 1991
22. Jiang WY, Raychaudhuri SP, Farber EM: Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 37:572-574, 1998
23. Johnson D, Lanahan A, Randy Buck C, Sehgal A, Morgan C, Mercer E: Expression and structure of the human NGF receptor. Cell 47:545-554, 1986
24. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF: The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 252:554-558, 1991
25. Kase H, Iwahashi K, Nakanishi S, et al: K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Bipohys Res Commun 142:436-440, 1987
26. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M: The trk protooncogene encodes a receptor for nerve growth factor. Cell 65:189-197, 1991
27. Koizumi S, Contreras ML, Matsuda Y, Hama T, Lazarovici P, Guroff G: K252a: A specific inhibitor of the action of nerve growth factor on PC 12 cells. J Neurosci 8:715-721, 1988
28. Lambiase A, Bracci-Laudiero L, Bonini S, et al: Human CD4 + T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allerg Clin Immunol 100:408-414, 1997
29. Lazarovici P, Levi BZ, Lelkes PI, et al: K252a inhibits the increase in c-fos transcription and the increase in intracellular calcium produced by nerve growth factor in PC 12 cells. J Neurosci Res 23:1-8, 1989
30. Leeman SE, Krause JE, Lembeck F: Substance P and related peptides: Cellular and molecular physiology. Ann N Y Acad Sci 632:263-271, 1991
31. Levine E, Cupp AS, Skinner MK: Role of neurotropins in rat embryonic testis morphogenesis (cord formation). Biol Reprod 62:132-142, 2000
32. Lindsay RM, Harmar AJ: Nerve growth factor regulates expression of neuropeptides genes in adult sensory neurons. Nature 337:362-364, 1989
33. Majdan M, Walsh GS, Aloyz R, Miller FD: TrkA mediates developmental sympathetic neuron survival in vivo by silencing an ongoing p75NTR-mediated death signal. J Cell Biol 155:1275-1285, 2001
34. Maliartchouk S, Saragovi U: Optimal nerve growth factor trophic signals mediated by synergy of trkA and p75 receptor-specific ligands. J Neurosci 17:6031-6037, 1997
35. Matsuda H, Koyama H, Sato H, et al: Role of nerve growth factor in cutaneous wound healing: Accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 187:297-306, 1998
36. Naukkarlnen A, Nickoloff BJ, Farber EM: Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 92:126-129, 1989
37. Nickoloff BJ, Kunkle SL, Burdick M, Strieter R: Severe combined immunodeficiency mouse and human psoriatic chimeras - Validation of a new model. Am J Pathol 146:580-588, 1995
38. Owen D, Logan A, Robinson P: A role of nerve growth factor in collateral reinnervation by cutaneous C-fibers in the rat. Brain Res 476:156-160, 1989
39. Pearce FL, Thompson HL: Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 372:379-393, 1986
40. Pincelli C, Haake AR, Benassi L, et al: Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): A role for BCL-2. J Invest Dermatol 109:757-764, 1997
41. Pincelli C, Sevignani C, Manfredini R, et al: Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 103:13-18, 1994
42. Raychaudhuri SP, Dutt S, Raychaudhuri SK, Sanyal M, Farber EM: Severe combined immunodeficiency mouse-human skin chimeras: A unique animal model for the study of psoriasis and cutaneous inflammation. Br J Dermatol 144:931-939, 2001a
43. Raychaudhuri SP, Farber EM: Are sensory nerves essential for the development of psoriasis lesions? J Am Acad Dermatol 28:488-489, 1993
44. Raychaudhuri SP, Jiang WY, Farber EM: Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 78:84-86, 1998
45. Raychaudhuri SP, Jiang WY, Farber EM, Schall T, Ruff M, Pert C: Identification of high levels of RANTES in the psoriatic keratinocytes. Acta Derm Venereol 79:9-11, 1999
46. Raychaudhuri SP, Jiang WY, Smoller BR, Farber EM: Nerve growth factor and its receptor system in psoriasis. Br J Dermatol 143:198-200, 2000a
47. Raychaudhuri SP, Raychaudhuri SK, Sanyal M, Weltman H, Farber EM: Role of neuroimmunologic inflammation in psoriasis in a SCID mouse-human skin animal model. FASEB J 14:1247, 2000b
48. Raychaudhuri SK, Raychaudhuri SP, Weltman H, Farber EM: Effect of nerve growth factor on endothelial cell biology: Proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 293:291-295, 2001b
49. Ross AH, Daou MC, McKinnon CA, Condon PJ, Lachyankar MB, Stephens RM: The neurotrophin receptor, gp 75, forms a complex with the receptor tyrosine kinase trkA. J Cell Biol 132:945-953, 1996
50. Schwartz J, Pearson J, Johnson E: Effect of exposure to anti-NGF on sensory neurons of adult rats and guinea pigs. Brain Res 244:378-381, 1982
51. Simone MD, De Santis S, Vignett E, Papa G, Amadori S, Aloe L: Nerve growth factor: A survey of activity on immune and hematopoetic cells. Hematol Oncol 17:1-10, 1993
52. Sugai J, Iizuka M, Kawakubo Y, et al: Histological and immunochemical studies of human psoriatic lesions transplanted onto SCID mice. J Dermatol Sci 17:85-92, 1998
53. Taniuchi M, Clark H, Jhonson E: Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci USA 83:4094-4098, 1996
54. Thorpe LW, Werrbach-Perez K, Perez-Polo JR: Effects of nerve growth factor on the expression of IL-2 receptors on cultured human lymphocytes. Ann NY Acad Sci 496:310-311, 1987
55. Wallengren J, Ekman R, Sunder F: Occurrence and distribution of neuropeptides in human skin: An immunocytochemical and immunohistochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol 67:185-192, 1987
56. Wilkinson DI, Theeuwes MI, Farber EM: Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: A comparison with epidermal growth factor. Exp Dermatol 3:239-245, 1994
57. Wyatt S, Davies AM: Regulation of expression of mRNAs encoding the nerve growth factor receptors p75 and trkA in developing sensory neurons. Development 119:635-648, 1993
58. Wyatt S, Shooter EM, Davies AM: Expression of the NGF receptor gene in sensory neurons and their cutaneous targets prior to and during innervation. Neuron 4:421-427, 1990